Marex Group plc Ordinary SharesMRXNASDAQ
Loading
R&D Expense Growth Under PressureDecelerating
Percentile Rank33
Studio
Year-over-Year Change

Year-over-year research & development expense growth

Latest
0.00%
↓ 100% vs avg
Percentile
P33
Within normal range
Average
72.77%
Historical baseline
PeriodValue
20250.00%
20240.00%
20230.00%
20220.00%
2021-100.00%
202019.41%
2019965.00%
2018-55.56%
2017-65.30%
2016-35.81%